Xie et al. (21) found that serotonin expression was also much higher in triple-negative (PR-, ER-, HER-2) breast cancer (TNBC) and triple-positive breast cancer (TPBC) compared to para-carcinoma tissues (PCTs). This evidence concerns the gene ERBB2 and breast cancer.